作者: L K Mullany , H-Y Fan , Z Liu , L D White , A Marshall
DOI: 10.1038/ONC.2011.70
关键词: KRAS 、 PI3K/AKT/mTOR pathway 、 Cancer research 、 Biology 、 Ovarian cancer 、 Gene expression profiling 、 Ovarian tumor 、 Molecular oncology 、 Phenotype 、 PTEN
摘要: Ovarian cancer is a complex and deadly disease that remains difficult to detect at an early curable stage. Furthermore, although some oncogenic (Kras, Pten/PI3K Trp53) pathways are frequently mutated, deleted or amplified in ovarian known, how these initiate drive specific morphological phenotypes tumor outcomes remain unclear. We recently generated Ptenfl/fl; KrasG12D; Amhr2-Cre mice disrupt the Pten gene express stable mutant form of KrasG12D surface epithelial (OSE) cells. On basis histopathologic criteria, developed low-grade serous papillary adenocarcinomas age with 100% penetrance. This highly reproducible phenotype provides first mouse model which study this subtype. OSE cells isolated from ovaries 5 10 weeks exhibit temporal changes expression Mullerian marker genes, grow soft agar develop ectopic invasive tumors recipient mice, indicating transformed. Gene profiling identified mRNAs microRNAs differentially expressed purified derived compared wild-type Mapping transcripts genes between data sets, Kras signature human cell lines array documented significant overlap, KRAS key driver transformation context. Two hallmarks elevated tumor-suppressor Trp53 (p53) its microRNA target, miR-34a-c. propose TRP53 miR-34a-c may exert negatively regulatory effects reduce proliferative potential leading adenocarcinoma phenotype.